Literature DB >> 21294262

Advanced optical imaging reveals the dependence of particle geometry on interactions between CdSe quantum dots and immune cells.

Jesse S Aaron1, Adrienne C Greene, Paul G Kotula, George D Bachand, Jerilyn A Timlin.   

Abstract

The biocompatibility and possible toxicological consequences of engineered nanomaterials, including quantum dots (QDs) due to their unique suitability for biomedical applications, remain intense areas of interest. We utilized advanced imaging approaches to characterize the interactions of CdSe QDs of various sizes and shapes with live immune cells. Particle diffusion and partitioning within the plasma membrane, cellular uptake kinetics, and sorting of particles into lysosomes were all independantly characterized. Using high-speed total internal reflectance fluorescence (TIRF) microscopy, we show that QDs with an average aspect ratio of 2.0 (i.e., rod-shaped) diffuse nearly an order of magnitude slower in the plasma membrane than more spherical particles with aspect ratios of 1.2 and 1.6, respectively. Moreover, more rod-shaped QDs were shown to be internalized into the cell 2-3 fold more slowly. Hyperspectral confocal fluorescence microscopy demonstrates that QDs tend to partition within the cell membrane into regions containing a single particle type. Furthermore, data examining QD sorting mechanisms indicate that endocytosis and lysosomal sorting increases with particle size. Together, these observations suggest that both size and aspect ratio of a nanoparticle are important characteristics that significantly impact interactions with the plasma membrane, uptake into the cell, and localization within intracellular vesicles. Thus, rather than simply characterizing nanoparticle uptake into cells, we show that utilization of advanced imaging approaches permits a more nuanced and complete examination of the multiple aspects of cell-nanoparticle interactions that can ultimately aid understanding possible mechanisms of toxicity, resulting in safer nanomaterial designs.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21294262     DOI: 10.1002/smll.201001619

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  6 in total

Review 1.  Toxicity of nanomaterials.

Authors:  Shahriar Sharifi; Shahed Behzadi; Sophie Laurent; M Laird Forrest; Pieter Stroeve; Morteza Mahmoudi
Journal:  Chem Soc Rev       Date:  2011-12-14       Impact factor: 54.564

2.  Gene Silencing of Human Neuronal Cells for Drug Addiction Therapy using Anisotropic Nanocrystals.

Authors:  Wing-Cheung Law; Supriya D Mahajan; Atcha Kopwitthaya; Jessica L Reynolds; Maixian Liu; Xin Liu; Guanying Chen; Folarin Erogbogbo; Lisa Vathy; Ravikumar Aalinkeel; Stanley A Schwartz; Ken-Tye Yong; Paras N Prasad
Journal:  Theranostics       Date:  2012-07-27       Impact factor: 11.556

3.  Transcriptome Profile Alteration with Cadmium Selenide/Zinc Sulfide Quantum Dots in Saccharomyces cerevisiae.

Authors:  Cullen Horstmann; Daniel S Kim; Chelsea Campbell; Kyoungtae Kim
Journal:  Biomolecules       Date:  2019-10-25

4.  Titanium dioxide nanoparticles stimulate sea urchin immune cell phagocytic activity involving TLR/p38 MAPK-mediated signalling pathway.

Authors:  Annalisa Pinsino; Roberta Russo; Rosa Bonaventura; Andrea Brunelli; Antonio Marcomini; Valeria Matranga
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

Review 5.  Nervous System Injury in Response to Contact With Environmental, Engineered and Planetary Micro- and Nano-Sized Particles.

Authors:  Tatiana Borisova
Journal:  Front Physiol       Date:  2018-06-26       Impact factor: 4.566

6.  Biodistribution and Tumors MRI Contrast Enhancement of Magnetic Nanocubes, Nanoclusters, and Nanorods in Multiple Mice Models.

Authors:  V Naumenko; A Garanina; A Nikitin; S Vodopyanov; N Vorobyeva; Y Tsareva; M Kunin; A Ilyasov; A Semkina; V Chekhonin; M Abakumov; A Majouga
Journal:  Contrast Media Mol Imaging       Date:  2018-09-24       Impact factor: 3.161

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.